-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Revance Therapeutics (NASDAQ:RVNC) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other research analysts also recently issued research reports about the stock. HC Wainwright restated a “neutral” rating and set a $6.60 price objective on shares […]
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other research analysts also recently issued research reports about the stock. HC Wainwright restated a “neutral” rating and set a $6.60 price objective on shares […]
